SINGAPORE (Nov 11): Cordlife Group posted $0.6 million in losses in 1QFY17, reversing from earnings of $7.3 million a year ago due to the absence of one-off fair value gains.
Revenue increased by 0.8% in 1Q17 mainly due to contribution from Stemlife, which became a subsidiary of Cordlife in Dec 2015.
In 1Q16, the group’s disposal of its shares in China Cord Blood Corporation (CCBC) allowed it to record $2.1 million of fair value gains, which was absent in this quarter’s set of financial results.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
